Real World Evidence Studies
Gathering real-life data for practical medical insights — bridging the gap between clinical research and everyday practice.
Generating Regulatory-Grade Real-World Evidence
Real-World Evidence (RWE) has become an essential component of modern drug development and lifecycle management, providing critical insights into how treatments perform in everyday clinical practice. At Omega CRO, we design and execute robust RWE studies that complement clinical trial data, inform regulatory decisions, and demonstrate the real-world value of therapeutic interventions.
Our experience spans large-scale population-based registries, post-market safety studies, treatment pattern analyses, and comparative effectiveness research. We integrate data from electronic health records (EHR), claims databases, patient-reported outcomes (PROs), and central laboratory results to generate high-quality, regulatory-grade evidence that meets the standards of FDA, EMA, and TİTCK.
Types of RWE Studies We Conduct
Prospective Registries
Large-scale, multi-center patient registries tracking real-world treatment patterns, clinical outcomes, and long-term safety across diverse patient populations.
Retrospective Database Studies
Analysis of EHR, claims data, and hospital records to evaluate treatment patterns, healthcare resource utilization, and comparative effectiveness.
Post-Market Surveillance
Phase IV safety monitoring studies required by regulatory authorities, tracking adverse events and long-term safety profiles in real-world settings.
PRO & Quality of Life Studies
Patient-reported outcome studies capturing real-world quality of life, treatment satisfaction, and symptom burden using validated instruments.
External Control Arms
Historical control arm construction from real-world data to support single-arm trial interpretation and regulatory submissions.
Natural History Studies
Prospective and retrospective studies characterizing disease progression, patient journeys, and clinical outcomes in the absence of treatment.
RWE Generation Expertise
Building on our extensive experience in population-based studies, we help clients effectively plan and conduct RWE studies.
Robust Protocol Design
Designing scientifically rigorous protocols for post-market safety and effectiveness studies, including non-interventional and observational study designs.
Multi-Source Data Integration
Seamlessly integrating data from EHR, claims databases, patient registries, and PROs to build comprehensive real-world datasets.
Endpoint Committee Management
Expert management of Clinical Endpoint Committees (CEC) and Data Safety Monitoring Boards (DSMB) for independent adjudication of clinical outcomes.
Advanced Biostatistics
Propensity score matching, inverse probability weighting, and advanced causal inference methods for robust comparative effectiveness analysis.
Application Scenarios in the Omega Ecosystem
How the Omega Research Ecosystem enhances RWE generation with longitudinal laboratory data, remote PRO collection, and long-term biobanking.
Omega Care
Remote PRO & Home Data Collection
Home-based patient-reported outcome capture via mobile platform; wearable sensor data integration; telemedicine follow-ups reducing loss-to-followup in long-term RWE studies.
Omega Genetics
Real-World Biomarker Profiling
Population-level genetic and molecular biomarker analysis for real-world treatment response studies and pharmacogenomic outcome research.
HelixLab
Longitudinal Laboratory Tracking
Centralized laboratory data integration for real-world biomarker trajectories (HbA1c, lipid panels, troponin) tracked over years in registry cohorts.
Omega Bio
Standardized Home Test Kits
Kit-based home collection devices (dried blood spots, self-sampling) enabling decentralized laboratory data generation for geographically dispersed RWE populations.
Omega Biorepository
Decade-Long Sample Archive
Multi-decade biobanking of serum, plasma, and tissue samples from registry participants enabling future biomarker discovery and retrospective analysis.
Animal Facility
Translational Disease Models
Animal models of disease progression to complement real-world human data, informing natural history understanding and drug target validation.
Generate Regulatory-Grade Real-World Evidence
Partner with Omega CRO for comprehensive RWE study design, execution, and analysis.
Talk to Our Experts